Clinical Trials in Belgium

• A Study of Disitamab Vedotin Alone and with Pembrolizumab in Urothelial Cancer That Expresses HER2 Not authorised
  2022-500030-28-00 Phase II Urothelial carcinoma Seagen Inc.
• A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polys… Not authorised
  2022-500228-31-00 Phase II/III Knee osteoarthritis pain Paradigm Biopharmaceuticals (USA) Inc.
• A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/… Not authorised
  2022-500410-26-00 Phase III Cystic Fibrosis University Medical Center Utrecht
• ABTECT-1 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -1 Not authorised
  2022-500535-36-00 Phase III Moderately to severely active ulcerative colitis Abivax
• ABTECT-2 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -2 Not authorised
  2022-500536-11-00 Phase III Moderately to severely active ulcerative colitis Abivax
• ABTECT-Maintenance – ABX464 Treatment Evaluation for ulcerative Colitis Therapy Not authorised
  2022-500537-84-00 Phase III Moderately to severely active ulcerative colitis Abivax
• An European multinational study of a personalized approach of human albumin administration in patients with cirrhosis of the liver and compl… Not authorised
  2022-501006-34-00 Phase III Liver cirrhosis European Foundation For The Study Of Chronic Liver Failure; Odense University Ho…
• Clinical trial of MK-7648A in adults and children with skin cancer Not authorised
  2022-501417-31-00 Phase III High-risk Resected Melanoma Merck Sharp & Dohme LLC
• A Study to Assess if BIIB080 Can Change Clinical Dementia Rating-Sum of Boxes Scores, and BIIB080 Safety and Tolerability When Injected Into… Not authorised
  2022-501644-15-00 Phase II Mild Cognitive Impairment due to Alzheimer's Disease Alzheim… Biogen Idec Research Limited
• A Phase I Study of RO7589831 in Participants with Advanced Solid Tumors Not authorised
  2023-503170-20-00 Phase I Advanced solid tumors F. Hoffmann-La Roche AG
• Baricitinib for treating hospital-acquired pneumonia in critically ill patients with a proinflammatory phenotype, an international phase II … Not authorised
  2023-503480-42-00 Phase II/III Hospital-acquired pneumonia Centre Hospitalier Universitaire De Nantes
• First administration in healthy volunteers of a single and increasing dose of a new molecule for the treatment of brain diseases Not authorised
  2023-505030-99-00 Phase I Post-Traumatic Stress Disorder (PTSD) Rest Therapeutics
• A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of a pDNA Vaccine Candidate Against COVID-19 in Healthy Adults Not authorised
  2023-505135-12-00 Phase I Covid-19 Prophylaxis Imam Abdulrahman Bin Faisal University
• Enhancing social attunement in autism via interpersonal sensorimotor synchronization therapy combined with single-dose intranasal oxytocin a… Not authorised
  2023-505253-41-00 Phase III Autism Spectrum Disorder (ASD) UZ Leuven
• Phase 3, Two-stage, Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancers that Progressed on PD-1/PD-L1 Inh… Not authorised
  2023-505311-20-00 Phase III Metastatic Non-Small Cell Lung Cancer Oncoc4 Inc.
• Searching for the right dose of perineural dexmedetomidine for a interscalene plexus block. Not authorised
  2023-506062-31-00 Phase III/IV Patients scheduled for shoulder operations Algemeen ziekenhuis Rivierenland
• IDE196 (DAROVASERTIB) IN COMBINATION WITH CRIZOTINIB VERSUS INVESTIGATOR’S CHOICE OF TREATMENT AS FIRST-LINE THERAPY IN HLA-A2 NEGATIVE META… Not authorised
  2023-506686-66-00 Phase II/III HLA-A2 negative metastatic uveal melanoma Ideaya Biosciences Inc.
• QIMPD SUBMISSION ONLY Not authorised
  2023-509510-11-00 Phase III NA F. Hoffmann-La Roche AG
• HER2 molecular imaging with 89Zr-trastuzumab PET/CT as a predictive biomarker for antibody-drug conjugate sequencing in patients with advanc… Not authorised
  2024-516253-49-00 Phase II advanced/metastatic HER2-positive breast carcinoma Institut Jules Bordet
• A Phase I-IIa Trial on the Safety and Preliminary Effectiveness of Intramyocardial Injection of Allogeneic Cardiac Atrial Stem Cells for the… Not authorised
  2024-517031-51-00 Phase I (FiH) Heart Failure CASC8
• Intubation Conditions in Morbidly Obese Patients with Rapid Sequence Induction: A Comparative Study of Rocuronium Dosing based on Ideal vs. … Not authorised
  2025-520977-37-00 Phase IV Obesity UZ Brussel
• A one-year study to assess if Xanomeline/Trospium (XT) can improve cognitive function in adults living with schizophrenia. Not authorised
  2025-523060-20-00 Phase III Schizophrenia European Group for Research in Schizophrenia Stichting
• A single center study to evaluate the safety and tolerability of oral Azathioprine in patients with ADPKD Not authorised
  2025-524313-86-00 Phase II Autosomal dominant polycystic kidney and liver disease UZ Leuven
• A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown
  2022-502779-40-99 Phase III Primary prevention of atherosclerotic cardiovascular disease… Novartis Pharma AG

Showing 1–24 of 2,338 trials